Patents Assigned to Cellink Bioprinting AB
-
Publication number: 20250136927Abstract: The invention relates to a composition for preparing a 3D scaffold for culturing cells and tissue, such as human cells and tissue. In particular embodiments, the present invention relates to a composition comprising a biocompatible polymer suitable for the preparation of a hydrogel, and a modified extracellular matrix (ECM) protein that is unreactive towards the biocompatible polymer, such that, after preparation of a hydrogel, the modified ECM protein is not covalently bound to the hydrogel. Compositions of the invention are suitable for use in 3D bioprinting, tissue engineering, drug screening, disease modelling and methods of treatment such as tissue regeneration.Type: ApplicationFiled: September 13, 2022Publication date: May 1, 2025Applicants: The University Court of the University of Glasgow, Imperial College Innovations Limited, Cellink Bioprinting ABInventors: Oana DOBRE, Sara TRUJILLO-MUNOZ, Matthew John DALBY, Manuel SALMERON-SANCHEZ, Liliang OUYANG, Molly STEVENS, Adel Itedal Namro REDWAN, Volodymyr KUZMENKO, Erik GATENHOLM, Hector MARTINEZ
-
Patent number: 12269217Abstract: A bioprinter (1) comprising at least one printhead (4a, 4b, 4c) with nozzle (5), a printbed (20) onto which the printhead (4a, 4b, 4c) is arranged to print an ink, an ultrasonic sensor arrangement arranged at the printbed (20), a controller (7) arranged to control movement of the printhead/nozzle (4a, 4b, 4c; 5) and to perform calibration of the printhead/nozzle (4a, 4b, 5 4c; 5) based on information from the ultrasonic sensor arrangement.Type: GrantFiled: May 3, 2021Date of Patent: April 8, 2025Assignee: Cellink Bioprinting ABInventors: Anton Andren, Peter Faltpihl, Erik Sternå, Adam Micha, Ali Cakir, Hector Martinez, Erik Gatenholm
-
Publication number: 20250001701Abstract: The present disclosure relates to a bioprinter system comprising a printbed, at least one of exchangeable and/or fixed toolhead, a cell culture monitor device, the device comprising a camera arranged to provide images of a cell culture or construct at the printbed, and a processing element arranged to monitor cell status at the printbed based on the provided images.Type: ApplicationFiled: September 11, 2024Publication date: January 2, 2025Applicant: Cellink Bioprinting ABInventors: Hector Martinez, Erik Gatenholm
-
Patent number: 12092530Abstract: A material cartridge arrangement (100, 101) for a dispensing system, comprising a material cartridge (2) having a first end (2a), an opposing second end (2b) and an ink material channel (5) extending between the first and second ends in the material cartridge (2), the ink material channel (5) being bounded by an ink material channel wall/walls (9) extending between the first (2a) and second ends (2b). An ink material pressurising device (3) is arranged to cause ink material hold in the ink material channel (5) to flow in a direction from said first end (2a) towards said second end (2b) and through an ink material outlet. At least one temperature sensing element (16) is arranged at a position along the direction of extension of the ink material channel (5) and arranged to measure a temperature at the ink material channel wall (9).Type: GrantFiled: August 31, 2021Date of Patent: September 17, 2024Assignee: Cellink Bioprinting ABInventors: Erik Gatenholm, Hector Martinez, Ginger Lohman, Mateusz Piotrzkowski, Bryan Jones, Eric Bronnenkant, Kyung Hun Jung
-
Patent number: 11931966Abstract: Systems and methods for optical assessments of bioink printability are described. The systems and methods include the use of hardware, software and optical targets to aid in the evaluation of bioink printability. The optical targets are developed and fabricated from 3D printable materials determined to be “nozzle fidelic” and/or materials that possess well characterized thermosensitivity. The optical targets make it possible to rapidly compare and evaluate bioink printability and can be easily customized and tailored for specific applications.Type: GrantFiled: January 25, 2019Date of Patent: March 19, 2024Assignee: CELLINK BIOPRINTING ABInventors: Patrick Thayer, Hany Abushall, Hector Martinez, Erik Gatenholm
-
Patent number: 11648336Abstract: The present invention relates to preparation of bioink composed of cellulose nanofibril hydrogel with native or synthetic Calcium containing particles. The concentration of the calcium containing particles can be between 1% and 40% w/v. Such bioink can be 3D Bioprinted with or without human or animal cells. Coaxial needle can be used where cellulose nanofibril hydrogel filled with Calcium particles can be used as shell and another hydrogel based bioink mixed with cells can be used as core or opposite. Such 3D Bioprinted constructs exhibit high porosity due to shear thinning properties of cellulose nanofibrils which provides excellent printing fidelity. They also have excellent mechanical properties and are easily handled as large constructs for patient-specific bone cavities which need to be repaired. The porosity promotes vascularization which is crucial for oxygen and nutrient supply. The porosity also makes it possible for further recruitment of cells which accelerate bone healing process.Type: GrantFiled: October 27, 2017Date of Patent: May 16, 2023Assignee: Cellink Bioprinting ABInventors: Paul Gatenholm, Hector Martinez, Michela Schettino, Erik Gatenholm
-
Patent number: 11590710Abstract: The present disclosure relates to a 3D bioprinter (1) comprising a base unit (2). The base unit (2) has a support (3) adapted for mounting of at least one toolhead (4), a communication interface part (5) for communication of data with the at least one toolhead (4), when mounted, and a base unit processing element (7) adapted to communicate with a toolhead processing element (8) of the at least one toolhead over said communication interface part (5). The present disclosure relates further to a 3D bioprinter toolhead. The present disclosure relates further to a method for bioprinting a construct.Type: GrantFiled: January 10, 2018Date of Patent: February 28, 2023Assignee: Cellink Bioprinting ABInventors: Erik Sternå, Jockum Svanberg, Erik Gatenholm, Hector Martinez
-
Patent number: 11548199Abstract: The present disclosure relates to a 3D printer (1) for 3D printing of a construct. The 3D printer (1) has a print bed (2). The 3D printer further comprises at least one actuating tool head (3) with an extrusion element (4), wherein the extrusion element and the print bed are movable in relation to each other. The 3D printer also comprises at least one sensor (5) arranged to sense a force applied to the print bed (2) by the extrusion element (4), or vice versa. The 3D printer additionally comprises a control element (7) arranged to detect when the sensed force exceeds a predetermined value and to record a position of the print bed or extrusion element related to the detection that the predetermined value is exceeded. The present disclosure also relates to corresponding methods and computer programs.Type: GrantFiled: June 1, 2018Date of Patent: January 10, 2023Assignee: Cellink Bioprinting ABInventors: Erik Sternå, Jockum Svanberg, Erik Gatenholm, Hector Martinez
-
Patent number: 11370171Abstract: Clean chamber technology for 3D printers and bioprinters is described. An airtight chamber or enclosure is provided so that positive pressure can be created inside the chamber. Unfiltered air is sucked in from outside into the chamber through a high efficiency filter such as a HEPA filter, using an electrically powered fan or blower, filtering out at least about 99% of particles and contaminants. The filtered air is then pushed into a 3D printing area inside the chamber and out through vents within the frame of the chamber. The technology provides a clean environment for 3D bioprinting of human tissue models and organs and 3D cell culturing without requiring clean room facilities.Type: GrantFiled: August 31, 2016Date of Patent: June 28, 2022Assignee: Cellink Bioprinting ABInventors: Erik Gatenholm, Ivan Tournier, Paul Gatenholm